Risk factor analysis of nosocomial lower respiratory tract infection in influenza-related acute respiratory distress syndrome. (July 2020)
- Record Type:
- Journal Article
- Title:
- Risk factor analysis of nosocomial lower respiratory tract infection in influenza-related acute respiratory distress syndrome. (July 2020)
- Main Title:
- Risk factor analysis of nosocomial lower respiratory tract infection in influenza-related acute respiratory distress syndrome
- Authors:
- Chen, Wei-Chih
Kao, Kuo-Chin
Sheu, Chau-Chyun
Chan, Ming-Cheng
Chen, Yu-Mu
Chien, Ying-Chun
Peng, Chung-Kan
Liang, Shinn-Jye
Hu, Han-Chung
Tsai, Ming-Ju
Fang, Wen-Feng
Perng, Wann-Cherng
Wang, Hao-Chien
Wu, Chieh-Liang
Yang, Kuang-Yao - Other Names:
- Lin Meng-Chih non-byline-author.
- Abstract:
- Background: Patients with severe influenza-related acute respiratory distress syndrome (ARDS) have high morbidity and mortality. Moreover, nosocomial lower respiratory tract infection (NLRTI) complicates their clinical management and possibly worsens their outcomes. This study aimed to explore the clinical features and impact of NLRTI in patients with severe influenza-related ARDS. Methods: This was an institutional review board approved, retrospective, observational study conducted in eight medical centers in Taiwan. From January 1 to March 31 in 2016, subjects were enrolled from intensive care units (ICUs) with virology-proven influenza pneumonia, while all of those patients with ARDS requiring invasive mechanical ventilation and without bacterial community-acquired pneumonia (CAP) were analyzed. Baseline characteristics, critical-illness data and clinical outcomes were recorded. Results: Among the 316 screened patients with severe influenza pneumonia, 250 with acute respiratory failure requiring intubation met the criteria of ARDS, without having bacterial CAP. Among them, 72 patients developed NLRTI. The independent risk factors for NLRTI included immunosuppressant use before influenza infection [odds ratio (OR), 5.669; 95% confidence interval (CI), 1.770–18.154], extracorporeal membrane oxygenation (ECMO) use after ARDS (OR, 2.440; 95% CI, 1.214–4.904) and larger corticosteroid dosage after ARDS (OR, 1.209; 95% CI, 1.038–1.407). Patients with NLRTI had higherBackground: Patients with severe influenza-related acute respiratory distress syndrome (ARDS) have high morbidity and mortality. Moreover, nosocomial lower respiratory tract infection (NLRTI) complicates their clinical management and possibly worsens their outcomes. This study aimed to explore the clinical features and impact of NLRTI in patients with severe influenza-related ARDS. Methods: This was an institutional review board approved, retrospective, observational study conducted in eight medical centers in Taiwan. From January 1 to March 31 in 2016, subjects were enrolled from intensive care units (ICUs) with virology-proven influenza pneumonia, while all of those patients with ARDS requiring invasive mechanical ventilation and without bacterial community-acquired pneumonia (CAP) were analyzed. Baseline characteristics, critical-illness data and clinical outcomes were recorded. Results: Among the 316 screened patients with severe influenza pneumonia, 250 with acute respiratory failure requiring intubation met the criteria of ARDS, without having bacterial CAP. Among them, 72 patients developed NLRTI. The independent risk factors for NLRTI included immunosuppressant use before influenza infection [odds ratio (OR), 5.669; 95% confidence interval (CI), 1.770–18.154], extracorporeal membrane oxygenation (ECMO) use after ARDS (OR, 2.440; 95% CI, 1.214–4.904) and larger corticosteroid dosage after ARDS (OR, 1.209; 95% CI, 1.038–1.407). Patients with NLRTI had higher in-hospital mortality and longer ICU stay, hospitalization and duration on mechanical ventilation. Conclusion: We found that immunosuppressant use before influenza infection, ECMO use, and larger steroid dosage after ARDS independently predict NLRTI in influenza-related ARDS. Moreover, NLRTI results in poorer outcomes in patients with severe influenza. The reviews of this paper are available via the supplemental material section. … (more)
- Is Part Of:
- Therapeutic advances in respiratory disease. Volume 14(2020)
- Journal:
- Therapeutic advances in respiratory disease
- Issue:
- Volume 14(2020)
- Issue Display:
- Volume 14, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 14
- Issue:
- 2020
- Issue Sort Value:
- 2020-0014-2020-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-07
- Subjects:
- acute respiratory distress syndrome -- influenza -- mortality -- nosocomial lower respiratory tract infection
Respiratory organs -- Diseases -- Periodicals
Respiratory agents -- Periodicals
Pulmonary pharmacology -- Periodicals
Respiratory Tract Diseases -- Periodicals
Respiratory System Agents -- therapeutic use -- Periodicals
Respiratory Tract Diseases -- drug therapy -- Periodicals
Lung Diseases -- drug therapy -- Periodicals
Appareil respiratoire -- Maladies -- Traitement -- Périodiques
Agents respiratoires -- Périodiques
Pharmacologie pulmonaire -- Périodiques
616.2005 - Journal URLs:
- http://tar.sagepub.com ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.1177/1753466620942417 ↗
- Languages:
- English
- ISSNs:
- 1753-4658
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 14755.xml